DRTS

Conviction 84HealthcareScan · Mon, Aug 10, 2026

DRTS$13.64+3.81%

ResistanceSupportVol 14Insider sell

Vol MA14 506.15K

May 11May 28Jun 16Jul 6Jul 23Aug 10

WSB mentions · 24h changelatest +100.00%· 2 mentions

May 11May 28Jun 16Jul 6Jul 23Aug 10

Alpha Tau Medical Ltd.Biotechnologywww.alphatau.com ↗

Price13.64

Change+3.81%

Gap+0.34%

Rel volume1.18×

Avg volume574.68K

Avg $ vol7.27M

SMA 2012.62

SMA 5011.53

SMA 2007.79

Price vs 50+18.34%

Price vs 200+75.14%

MA stackbullish

50/200 cross—

Supertrendup · 11.11

RSI (14)62

MACD hist0.05

MACD crossbull · 1d

Stoch %K / %D97 / 81

ADX (14)19

+DI / −DI27 / 18

RSI divergence—

MACD divergence—

ATR %+5.95%

ADR %6.46%

52w high13.64

52w low3.06

From 52w high+0.00%

Above 52w low+345.75%

New 52w highYes

SqueezeOff

Bollinger width22.91%

%B0.85

Donchian pos91.16%

Donchian high13.90

Donchian low10.96

AVWAP (52w high)12.73

vs AVWAP high+7.16%

AVWAP (52w low)9.14

vs AVWAP low+49.19%

OBV trendFlat

Chaikin MF (20)-0.05

Today vs 20d1.18×

Avg vol (14d)506.14K

Avg vol (20d)574.68K

Avg $ vol (20d)7.27M

Market cap1.2B

RS 3m (vs SPY)+61.69%

RS 6m (vs SPY)+77.43%

RS line new highNo

Trend template8/8

Technical rank91.9

1 week+14.43%

1 month+7.32%

3 months+60.28%

6 months+91.84%

1 year+317.13%

YTD+182.40%

P/E—

P/B15.57

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq0.00

Current7.45

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target13.50

Target upside-1.03%

Analyst ratingBuy

Institutional5.78%

Ent. value1.19B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out90.33M

Employees121

ListedTue, Mar 8, 2022

Free float46.86M

Float %53.2%

Short interest2.98M

Days to cover3.7d

Short volume63.2%

Squeeze score49 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.26 vs −$0.13

Last surprise-100.0% miss

Setup gradeA

Conviction84 / 100

Pattern quality—

Tech rank91.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance14.01

Support10.09

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in DRTS

All disclosures →

No recent disclosed trades by Congress in DRTS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DRTS · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-06	Exercise	2.27K	$7K	2026-07-06	2026-07-07
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-06	Sell	2.27K	$32K	2026-07-06	2026-07-07
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-02	Exercise	17.87K	$53K	2026-07-02	2026-07-06
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-07-02	Sell	17.87K	$232K	2026-07-02	2026-07-06
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-25	Sell	4.22K	$46K	2026-06-25	2026-06-26
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-25	Sell	15.78K	$174K	2026-06-25	2026-06-26
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-23	Sell	15K	$142K	2026-06-23	2026-06-25
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-23	Sell	2.5K	$25K	2026-06-23	2026-06-25
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-03	Sell	17.5K	$191K	2026-06-03	2026-06-04
Levy Raphi Chief Financial Officer · Ordinary Shares · 2026-06-03	Sell	15K	$161K	2026-06-03	2026-06-04

SEC filings

EDGAR filings in DRTS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.